Stem Cell Therapies for Amyotrophic Lateral Sclerosis : Recent Advances and Prospects for the Future

J. Lunn,Stacey A. Sakowski,E. Feldman

Published 2014 in Unknown venue

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2014
Venue
Unknown venue
Publication date
Unknown publication date
Fields of study
Not labeled
Identifiers
No identifiers available.
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

Differentiation of CD133+ Stem Cells From Amyotrophic Lateral Sclerosis Patients Into Preneuron Cells
2013cited by this paper
Nonviral Methods for Inducing Pluripotency to Cells
2013cited by this paper
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.
2013cited by this paper
Mesenchymal Stem Cells and the Treatment of Conditions and Diseases: The Less Glittering Side of a Conspicuous Stem Cell for Basic Research
2013cited by this paper
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
2013cited by this paper
Stem cell therapy in amyotrophic lateral sclerosis.
2013cited by this paper
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis.
2013cited by this paper
Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
2013cited by this paper
Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis
2013cited by this paper
Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds
2013cited by this paper
Culturing and expansion of "clinical grade" precursors cells from the fetal human central nervous system.
2013cited by this paper
Comparison of phenotypic markers and neural differentiation potential of multipotent adult progenitor cells and mesenchymal stem cells.
2013cited by this paper
A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.
2013cited by this paper
Neural Induction with Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an Amyotrophic Lateral Sclerosis Mouse Model
2013cited by this paper
Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosis.
2012cited by this paper
Generation of induced pluripotent stem cells from Asian patients with chronic neurodegenerative diseases.
2012cited by this paper
Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention.
2012cited by this paper
Oligodendroglia metabolically support axons and contribute to neurodegeneration
2012cited by this paper
Positron Emission Tomography Reporter Genes and Reporter Probes: Gene and Cell Therapy Applications
2012cited by this paper
How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
2012cited by this paper
Human Neural Stem Cell Replacement Therapy for Amyotrophic Lateral Sclerosis by Spinal Transplantation
2012cited by this paper
Translational stem cell therapy for amyotrophic lateral sclerosis
2012influential reference
The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate.
2012cited by this paper
Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation
2012cited by this paper
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
2012cited by this paper
Host induction by transplanted neural stem cells in the spinal cord: further evidence for an adult spinal cord neurogenic niche.
2012cited by this paper
Lumbar Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis: Results of a Phase I Trial in 12 Patients
2012cited by this paper
Misregulated RNA processing in amyotrophic lateral sclerosis.
2012cited by this paper
177 Pre-clinical Validation of Superparamagnetic Iron Oxide Nanoparticle-Labeled Neural Stem Cells for In Vivo Tracking and Post-Mortem Identification in the Spinal Cord.
2012cited by this paper
Intracerebroventricular Injection of Encapsulated Human Mesenchymal Cells Producing Glucagon-Like Peptide 1 Prolongs Survival in a Mouse Model of ALS
2012cited by this paper
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.
2012cited by this paper
Feasibility, Safety, and Preliminary Proof of Principles of Autologous Neural Stem Cell Treatment Combined with T-Cell Vaccination for ALS Patients
2012cited by this paper
Human Skeletal Muscle Stem Cell Antiinflammatory Activity Ameliorates Clinical Outcome in Amyotrophic Lateral Sclerosis Models
2012cited by this paper
Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
2012cited by this paper
Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
2012cited by this paper
Neurotrophic Bone Marrow Cellular Nests Prevent Spinal Motoneuron Degeneration in Amyotrophic Lateral Sclerosis Patients: A Pilot Safety Study
2012cited by this paper
Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis
2012cited by this paper
Olfactory Ensheathing Cell Neurorestorotherapy for Amyotrophic Lateral Sclerosis Patients: Benefits from Multiple Transplantations
2012cited by this paper
Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells
2012cited by this paper
Cervical Multilevel Intraspinal Stem Cell Therapy: Assessment of Surgical Risks in Gottingen Minipigs
2011cited by this paper
Intraspinal Injection of Human Umbilical Cord Blood-Derived Cells Is Neuroprotective in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
2011cited by this paper
Intracerebroventricular Administration of Human Umbilical Cord Blood Cells Delays Disease Progression in Two Murine Models of Motor Neuron Degeneration
2011cited by this paper
Optimization of Immunosuppressive Therapy for Spinal Grafting of Human Spinal Stem Cells in a Rat Model of ALS
2011cited by this paper
Mitochondrial disfunction as a cause of ALS.
2011cited by this paper
Platform and Cannula Design Improvements for Spinal Cord Therapeutics Delivery
2011cited by this paper
Olfactory Ensheathing Cell Transplantation Into Spinal Cord Prolongs the Survival of Mutant SOD1G93A ALS Rats Through Neuroprotection and Remyelination
2011cited by this paper
Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.
2011cited by this paper
Repeated courses of granulocyte colony‐stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study
2011cited by this paper
Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice
2011cited by this paper
Glial Cells in Amyotrophic Lateral Sclerosis
2011cited by this paper
Stem cell technology for the study and treatment of motor neuron diseases.
2011influential reference
Defective Neuromuscular Transmission in the SOD1G93A Transgenic Mouse Improves After Administration of Human Umbilical Cord Blood Cells
2011cited by this paper
Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation.
2010cited by this paper
Nuclear reprogramming to a pluripotent state by three approaches
2010cited by this paper
Characterization of a human fetal spinal cord stem cell line, NSI‐566RSC, and its induction to functional motoneurons
2010cited by this paper
Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study
2010cited by this paper
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
2010cited by this paper
Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors.
2010cited by this paper
Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage.
2010cited by this paper
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
2010cited by this paper
Bone Marrow-Derived Stromal Cells from Amyotrophic Lateral Sclerosis Patients Have Diminished Stem Cell Capacity
2010cited by this paper
No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS
2010cited by this paper
Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
2010cited by this paper
Neuropathology of Olfactory Ensheathing Cell Transplantation into the Brain of Two Amyotrophic Lateral Sclerosis (ALS) Patients
2009cited by this paper
In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles
2009cited by this paper
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
2009cited by this paper
Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery
2009cited by this paper
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
2009cited by this paper
Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients.
2009cited by this paper
Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice
2009cited by this paper
CERVICAL SPINAL CORD THERAPEUTICS DELIVERY: PRECLINICAL SAFETY VALIDATION OF A STABILIZED MICROINJECTION PLATFORM
2009cited by this paper
Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging.
2009cited by this paper
Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
2009cited by this paper
Transient Recovery in a Rat Model of Familial Amyotrophic Lateral Sclerosis after Transplantation of Motor Neurons Derived from Mouse Embryonic Stem Cells
2009cited by this paper
Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: Differentiation and structural integration into the segmental motor circuitry
2009cited by this paper
Human umbilical cord blood treatment in a mouse model of ALS : optimization of cell dose
2009cited by this paper
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.
2008cited by this paper
Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis.
2008cited by this paper
Stem cell treatment in Amyotrophic Lateral Sclerosis.
2008cited by this paper
Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
2008cited by this paper
Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study
2008cited by this paper
Efficient In Vitro Labeling of Human Neural Precursor Cells with Superparamagnetic Iron Oxide Particles: Relevance for In Vivo Cell Tracking
2008cited by this paper
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
2008cited by this paper
In vitro evidence for impaired neuroprotective capacities of adult mesenchymal stem cells derived from a rat model of familial amyotrophic lateral sclerosis (hSOD1(G93A)).
2008cited by this paper
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
2008cited by this paper
Focal Transplantation-based Astrocyte Replacement is Neuroprotective in a Model of Motor Neuron Disease
2008cited by this paper
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
2008cited by this paper
Pilot study of granulocyte colony stimulating factor (G‐CSF)‐mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS)
2008cited by this paper
Bone Marrow Mesenchymal Stem Cells from Healthy Donors and Sporadic Amyotrophic Lateral Sclerosis Patients
2008cited by this paper
Olfactory ensheathing glia injections in Beijing: Misleading patients with ALS
2007cited by this paper
GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS
2007cited by this paper
Comparison of Imaging Techniques for Tracking Cardiac Stem Cell Therapy
2007cited by this paper
Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors
2007cited by this paper
Targeted Spinal Cord Therapeutics Delivery: Stabilized Platform and Microelectrode Recording Guidance Validation
2007cited by this paper
Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1G93A G1H transgenic mouse model of amyotrophic lateral sclerosis
2007cited by this paper
Axonal Degeneration in Motor Neuron Disease
2007cited by this paper
Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis.
2007cited by this paper
Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal Cord
2007cited by this paper
Human Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats
2006cited by this paper
Motor Neuron Degeneration Promotes Neural Progenitor Cell Proliferation, Migration, and Neurogenesis in the Spinal Cords of Amyotrophic Lateral Sclerosis Mice
2006cited by this paper

CITED BY

Iranian clinical practice guideline for amyotrophic lateral sclerosis
2023cites this paper
The Safety and Efficacy of Stem Cell Therapy as an Emerging Therapy for ALS: A Systematic Review of Controlled Clinical Trials
2021cites this paper
GLT1 gene delivery based on bone marrow-derived cells ameliorates motor function and survival in a mouse model of ALS
2021cites this paper
Repeated intramuscular transplantations of hUCB-MSCs improves motor function and survival in the SOD1 G93A mice through activation of AMPK
2020cites this paper
Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients
2020cites this paper
The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy – a perspective on cell biological mechanisms
2017cites this paper
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection
2016cites this paper
Autocrine Production of IGF‐I Increases Stem Cell‐Mediated Neuroprotection
2015cites this paper
Grafted Bone Marrow Stromal Cells
2015cites this paper
The glutamate hypothesis in ALS: pathophysiology and drug development.
2014cites this paper
Exploring deregulated signals involved in motor neuron-microglia cross-talk in ALS
2014cites this paper
Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs
2014influential citation